Header Logo

Connection

SANJEEV VASUDEVAN to Sirolimus

Back to Details
This is a "connection" page, showing publications SANJEEV VASUDEVAN has written about Sirolimus.
SANJEEV VASUDEVAN
Connection Strength
0.058
Sirolimus
  1. p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy. Clin Cancer Res. 2017 Nov 01; 23(21):6629-6639.
    View in: PubMed
    Score: 0.030
  2. Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia. Pediatr Blood Cancer. 2017 05; 64(5).
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.